Nov 18, 2025 08:00AM
Oct 20, 2025 04:24PM
Oct 20, 2025 04:19PM
Sep 11, 2025 09:18AM
Sep 9, 2025 09:28AM
Sep 9, 2025 09:28AM
Aug 25, 2025 09:15AM Aditxt subsidiary Adimune plans FDA trials for autoimmune treatments
Aug 25, 2025 09:15AM
Aug 21, 2025 08:56AM
Aug 19, 2025 09:39AM
Aug 14, 2025 08:46AM
Aug 5, 2025 08:46AM
Jul 15, 2025 09:12AM
Jun 11, 2025 08:14AM Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 2, 2025 08:17AM
Apr 2, 2025 08:15AM
Mar 24, 2025 08:30AM
Mar 24, 2025 08:15AM Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs o
Mar 18, 2025 07:22AM
Mar 17, 2025 08:15AM
Mar 17, 2025 08:15AM
Mar 6, 2025 08:15AM
Mar 6, 2025 08:15AM
Feb 14, 2025 05:06PM
Nov 14, 2024 04:36PM Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Nov 6, 2024 08:00AM
Oct 31, 2024 08:32AM
Oct 31, 2024 08:30AM
Oct 31, 2024 07:15AM Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Oct 28, 2024 08:15AM
Oct 21, 2024 08:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 08:15AM
Oct 8, 2024 08:15AM
Oct 3, 2024 08:16AM
Oct 3, 2024 08:15AM Aditxt Delivers Shareholder Update and 2024 Year-End Plan
Sep 24, 2024 08:15AM
Sep 24, 2024 08:15AM
Sep 20, 2024 08:15AM
Sep 9, 2024 08:15AM
Aug 20, 2024 08:17AM
Aug 20, 2024 08:17AM
Aug 14, 2024 07:00AM Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
Jul 25, 2024 09:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All